The University of Chicago Header Logo

Connection

John Fung to Mice, Inbred Strains

This is a "connection" page, showing publications John Fung has written about Mice, Inbred Strains.
Connection Strength

0.338
  1. Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1168-9.
    View in: PubMed
    Score: 0.034
  2. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Immunology. 1995 May; 85(1):82-7.
    View in: PubMed
    Score: 0.030
  3. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. Transplant Proc. 1994 Jun; 26(3):1211.
    View in: PubMed
    Score: 0.029
  4. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc. 1993 Feb; 25(1 Pt 1):362-3.
    View in: PubMed
    Score: 0.026
  5. Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities. Transplant Proc. 1992 Aug; 24(4):1605-6.
    View in: PubMed
    Score: 0.025
  6. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation. 2012 Feb 15; 93(3):272-82.
    View in: PubMed
    Score: 0.024
  7. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology. 2009 Dec; 50(6):1981-91.
    View in: PubMed
    Score: 0.021
  8. Regulatory dendritic cells modulate immune responses via induction of T-cell apoptotic death. Microsurgery. 2006; 26(1):21-4.
    View in: PubMed
    Score: 0.016
  9. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation. 2001 Oct 27; 72(8):1423-32.
    View in: PubMed
    Score: 0.012
  10. Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses. Transplant Proc. 1999 Feb-Mar; 31(1-2):115.
    View in: PubMed
    Score: 0.010
  11. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.
    View in: PubMed
    Score: 0.010
  12. Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. Transplant Proc. 1999 Feb-Mar; 31(1-2):784.
    View in: PubMed
    Score: 0.010
  13. Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc. 1999 Feb-Mar; 31(1-2):797.
    View in: PubMed
    Score: 0.010
  14. Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. Transplant Proc. 1999 Feb-Mar; 31(1-2):1195.
    View in: PubMed
    Score: 0.010
  15. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.
    View in: PubMed
    Score: 0.010
  16. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. Transplant Proc. 1998 Jun; 30(4):941-2.
    View in: PubMed
    Score: 0.009
  17. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1081-2.
    View in: PubMed
    Score: 0.009
  18. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996 Sep 15; 62(5):659-65.
    View in: PubMed
    Score: 0.008
  19. Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. Transplant Proc. 1996 Apr; 28(2):733-4.
    View in: PubMed
    Score: 0.008
  20. The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. Transplant Proc. 1995 Feb; 27(1):270.
    View in: PubMed
    Score: 0.007
  21. Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
    View in: PubMed
    Score: 0.007
  22. Orthotopic liver transplantation in the mouse. Transplantation. 1991 Sep; 52(3):562-4.
    View in: PubMed
    Score: 0.006
  23. Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers. Transplant Proc. 1991 Feb; 23(1 Pt 1):705-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.